|
|
|
|
|
|||||||||||||||||||||||
|
Pork Pancreas Enzymes
The pancreas produces digestive enzymes which serve to break down complex carbohydrates, proteins, and fats into the nutrient forms required for proper absorption. Pancreatic enzymes are important in balancing physiology and creating a more inhospitable environment for cancer. Studies published in the Journal of Experimental Medicine and Surgery demonstrate that enzymes, protect breast cancer-prone mice from the disease. Studies done at the turn-of-the-century by John Beard, Professor of Embryology at the University of Edinburgh, demonstrate that the placenta of mammals stops growing when the pancreas of the fetus begins secreting pancreatic enzymes. Something in the enzymes seems to make mortal, what are otherwise immortal (embryonic) cells. Since cancer cells are immortal, it seems reasonable that pancreatic enzymes will stop them from growing as well. Beard injected trypsin (a common pancreatic enzyme) into mice tumors. In 1905, he announced his findings at the Biological Society of Liverpool. Cancer, he said, has ceased to be a problem for the embryologist. Beard had arrived at a fundamental understanding of cancer through his observations of embryo development; cancer is caused by the failure of a normal process that clears cells prone to immortality (now called apoptosis, or programmed cell death). Based on his embryology studies, he argued that cancer cells cannot live in the presence of pancreatic enzymes. Although, he was attacked by his colleagues at the time, studies published since then help support the validity of his concepts. As Beard predicted, cancer cells use their own mutant forms of enzymes to eat away surrounding tissue. But cancer itself is subject to the bodys natural enzymes, the pancreatic enzymes. These enzymes are stronger than cancer enzymes because they can degrade cancer cells. Beard called it the antithesis of two digestions. Cancer cells cannot withstand the pH environment created by pancreatic enzymes. Beard injected enzymes near the site of his patients tumors. In 1975, a study published in the journal Science confirmed that pancreatic enzymes do enter the blood stream through the gut, and are recycled back to the pancreas. That study verified that oral enzymes have the potential to reach cancerous tissue by ingestion. Pancreatic enzymes can degrade anti-neoplastin peptides, so cancer patients taking this therapy should avoid taking pancreatic enzymes at the same time that other peptide therapies are in the stomach. The pancreas glandular tissue used in this product is derived from government-inspected, range-fed animals, raised in New Zealand or Australia without hormones or antibiotics. The glandular material is frozen, then subjected to a high vacuum that vaporizes moisture directly from the solid state, thereby maintaining biological activity of the enzymes and hormones.
Dosage and
use
|
|||||||||||||||||||||||
|
|
|||||||||||||||||||||||
|
These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease
|
|||||||||||||||||||||||